한글목차

세계의 의료기기 상환 시장은 선진 의료 기술의 보급 확대, 의료 정책 진화, 세계 보험 적용 범위의 확대를 배경으로 현저한 성장을 이루고 있습니다. 시장 규모는 2026년에 8,126억 달러에 이를 전망이고, 2033년까지 1조 3,348억 달러로 확대될 것으로 예측되고 있으며, 예측 기간 동안 CAGR은 6.2%로 성장이 전망됩니다. 상환 정책은 환자가 의료기기를 이용할 수 있도록 하고, 의료 제공업체를 지원하며, 의료 기술의 혁신을 촉진하는 데 매우 중요합니다.

의료기기 상환 제도를 통해 의료 시스템은 비용 효율적인 솔루션을 제공할 수 있을 뿐만 아니라 제조업자와 공급자가 지속 가능한 수익원을 유지할 수 있게 됩니다. 세계적으로 정부 주도의 이니셔티브와 보험 프로그램이 확대되고 있는 것도 의료기기의 도입을 더욱 촉진하고, 환자 케어 전체의 향상에 기여하고 있습니다.

시장 인사이트

의료기기 상환 시장은 병원, 클리닉, 진단실험실에서 사용되는 광범위한 장비를 다룹니다. 수요는 주로 만성 질환 증가, 노화 및 비용 효율적인 의료 서비스의 필요성에 의해 견인되고 있습니다.

현재 북미는 성숙한 상환 인프라, 광범위한 보험 적용 범위, 선진 의료기기의 높은 도입률로 시장을 선도하고 있습니다. 유럽은 유리한 정책 및 관민 연계 상환 프로그램에 의해 지원되고 그에 이어집니다. 한편 아시아태평양은 의료 인프라 확대, 보험 가입률 상승, 선진 의료 기술에 대한 인식이 높아짐에 따라 고성장 시장으로 대두되고 있습니다.

이 시장은 매우 유동적이며 규제 변경, 가격 압력 및 혁신에 영향을 받기 쉬운 특성이 있습니다. 효과적인 상환 제도는 환자가 합리적인 가격으로 의료기기를 이용할 수 있도록 하는 동시에 제조업체의 성장을 지원하는 데 필수적입니다.

시장 성장 촉진요인

의료기기 상환 시장의 성장은 다음의 주요 요인별로 추진되고 있습니다.

• 1. 의료비 지출 증가 : 정부 및 민간 의료 제공업체는 의료기기에 상당한 투자를 하고 있으며, 상환 서비스 수요를 견인하고 있습니다.
• 2. 만성질환 증가 : 심혈관질환, 당뇨병, 암 등의 질환에는 첨단 진단 및 치료기기가 필요하며, 상환의 필요성이 높아지고 있습니다.
• 3. 기술 진보 : 저침습 수술, 웨어러블 디바이스, 진단 기기의 혁신이 상환 프레임워크 하에서의 도입을 촉진하고 있습니다.
• 4. 지원적인 정책 및 규제 : 정부나 보험기업별 상환 프로세스의 효율화가 진행되어 환자의 접근 개선과 기기 도입 촉진으로 이어지고 있습니다.
• 5. 외래 및 재택 치료 환경으로의 이행 : 분산형 의료의 확대 동향에 의해 병원외 환경에서 상환 대상이 되는 의료기기에 수요가 생기고 있습니다.

비즈니스 기회

이 시장은 이해 관계자에게 여러 기회를 제공합니다.

• 지불자와의 연계 강화 : 보험사는 보다 폭넓은 기기의 적용 범위를 확대하여 환자의 액세스 향상을 도모할 수 있습니다.
• 의료 제공업체 간 연계 : 병원, 검사 기관, 진료소는 상환 제도를 활용하여 의료 제공 체제의 개선을 도모할 수 있습니다.
• 기술 통합 : 디지털 헬스툴 및 원격 의료는 청구 처리의 효율화, 사무 부담의 경감, 효율성의 향상에 기여합니다.
• 신흥 시장의 잠재력 : 아시아태평양, 라틴아메리카, 중동 및 아프리카에서는 의료 투자 증가, 보험 가입 확대, 정부별 상환 프로그램 도입으로 현저한 성장이 예상됩니다.

지역별 분석

• 북미 : 견고한 상환 프레임워크, 높은 의료 지출, 고급 의료 기술의 광범위한 도입으로 시장을 이끌고 있습니다.
• 유럽 : 정부 주도 시책, 관민 연계 상환 프로그램, 병원 및 외래 진료에 있어서 의료기기 도입 증가에 의해 성장이 지지되고 있습니다.
• 아시아태평양 : 의료 의식 증가, 보험 보급률 증가, 의료 인프라에 대한 정부 투자로 인해 가장 빠르게 성장하는 지역입니다.
• 라틴아메리카 : 진화하는 상환 정책, 민간 의료 확대, 정부 지원 강화로 완만한 성장이 예상됩니다.
• 중동 및 아프리카 : 의료 인프라 투자 증가, 보험 적용 범위 확대, 선진 의료기기 도입 확대로 새로운 기회가 탄생하고 있습니다.

주요 진출 기업

본 시장은 경쟁이 치열해 주요 의료기기 제조업체, 보험사, 의료 제공업체가 성장을 적극적으로 견인하고 있습니다. 주요 진출 기업은 다음과 같습니다.

• Medtronic
• Johnson & Johnson
• Abbott Laboratories
• Boston Scientific
• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Stryker Corporation
• Zimmer Biomet
• Becton, Dickinson and Company(BD)
• UnitedHealth Group
• CVS Health/Aetna
• Cigna Corporation
• Humana Inc.
• Allianz/Aviva/WellCare Health Plans

이러한 조직은 전략적 제휴, 합병 및 협업에 주력하여 상환 네트워크 확대, 시장 범위 확대, 의료기기 기술의 혁신을 촉진하고 있습니다.

시장 세분화

청구 내용별 :

• 부분 상환
• 전액 상환

용도별 :

• 공적 지불자
• 민간 지불자

서비스 제공업체별 :

• 진료소
• 병원
• 검사기관
• 기타

지역별 :

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

목차

제1장 주요 요약

• 세계의 의료기기 상환 시장 현황
• 예측
• 주요 시장 동향
• 지역별 스냅샷(금액, 2026년)
• 애널리스트 추천

제2장 시장 개요

• 시장 정의 및 세분화
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 시장 기회
• 밸류체인 분석
• COVID-19의 영향 분석
• Porter's Five Forces 분석
• 러시아 및 우크라이나 분쟁의 영향
• PESTLE 분석
• 규제 분석
• 가격 동향 분석
  • 현재의 가격 및 장래 예측(2025-2033년)
  • 가격 영향요인

제3장 세계의 의료기기 상환 시장 전망(2020-2033년)

• 세계의 의료기기 상환 시장 전망 : 청구 내용별, 금액(10억 달러)(2020-2033년)
  • 부분 상환
  • 전액 상환
• 세계의 의료기기 상환 시장 전망 : 용도별, 금액(10억 달러)(2020-2033년)
  • 공적 지불자
  • 민간 지불자
• 세계의 의료기기 상환 시장 전망 : 서비스 제공업체별, 금액(10억 달러)(2020-2033년)
  • 진료소
  • 병원
  • 검사기관
  • 기타
• 세계의 의료기기 상환 시장 전망 : 지역별, 금액(10억 달러)(2020-2033년)
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제4장 북미의 의료기기 상환 시장 전망(2020-2033년)

제5장 유럽의 의료기기 상환 시장 전망(2020-2033년)

제6장 아시아태평양의 의료기기 상환 시장 전망(2020-2033년)

제7장 라틴아메리카의 의료기기 상환 시장 전망(2020-2033년)

제8장 중동 및 아프리카의 의료기기 상환 시장 전망(2020-2033년)

제9장 경쟁 구도

• 기업 대 부문 히트맵
• 기업의 시장 점유율 분석(2025년)
• 경쟁 대시보드
• 기업 프로파일
  • Medtronic
  • Johnson & Johnson
  • Abbott Laboratories
  • Boston Scientific
  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Stryker Corporation
  • Zimmer Biomet
  • Becton, Dickinson and Company(BD)

제10장 부록

영문목차

The global Medical Devices Reimbursement Market is experiencing significant growth, driven by the rising adoption of advanced medical technologies, evolving healthcare policies, and increasing insurance coverage worldwide. The market is expected to reach USD 812.6 billion in 2026 and expand to USD 1,334.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of 6.2% over the forecast period. Reimbursement policies are vital for ensuring patient access to medical devices, supporting healthcare providers, and promoting innovation in medical technology.

Reimbursement for medical devices enables healthcare systems to deliver cost-effective solutions while ensuring that manufacturers and providers maintain sustainable revenue streams. Growing government initiatives and insurance programs across the globe are further boosting the uptake of medical devices, improving overall patient care.

Market Insights

The medical devices reimbursement market covers a broad spectrum of devices used across hospitals, physician offices, and diagnostic laboratories. Demand is primarily fueled by the increasing prevalence of chronic diseases, aging populations, and the need for cost-efficient healthcare services.

Currently, North America leads the market due to its mature reimbursement infrastructure, widespread insurance coverage, and high adoption of advanced medical devices. Europe follows closely, supported by favorable policies and public-private reimbursement programs. Meanwhile, the Asia Pacific region is emerging as a high-growth market owing to expanding healthcare infrastructure, rising insurance penetration, and increasing awareness of advanced medical technologies.

The market is highly dynamic and sensitive to regulatory changes, pricing pressures, and technological innovations. Effective reimbursement systems are essential for ensuring that medical devices are accessible to patients at affordable costs while supporting manufacturers' growth.

Market Drivers

The growth of the medical devices reimbursement market is propelled by several key factors:

• 1. Rising Healthcare Expenditure - Governments and private healthcare providers are investing heavily in medical devices, driving demand for reimbursement services.
• 2. Increasing Prevalence of Chronic Diseases - Conditions such as cardiovascular diseases, diabetes, and cancer require advanced diagnostic and therapeutic devices, increasing the need for reimbursement.
• 3. Technological Advancements - Innovations in minimally invasive procedures, wearable devices, and diagnostic equipment are boosting adoption under reimbursement frameworks.
• 4. Supportive Policies and Regulations - Reimbursement processes are being streamlined by governments and insurers, improving patient access and promoting device adoption.
• 5. Shift Towards Outpatient and Homecare Settings - The growing trend of decentralized healthcare has created demand for devices reimbursed in non-hospital environments.

Business Opportunities

The market presents multiple opportunities for stakeholders:

• Enhanced Payer Engagement - Insurers can expand coverage for a broader range of devices, increasing patient access.
• Provider Collaboration - Hospitals, diagnostic labs, and physician offices can leverage reimbursement to improve healthcare delivery.
• Technology Integration - Digital health tools and telemedicine can streamline claims processing, reduce administrative burdens, and improve efficiency.
• Emerging Market Potential - Asia Pacific, Latin America, and the Middle East & Africa offer significant growth due to increasing healthcare investment, insurance adoption, and government reimbursement programs.

Regional Analysis

• North America: Dominates the market due to robust reimbursement frameworks, high healthcare expenditure, and widespread adoption of advanced medical technologies.
• Europe: Growth supported by government initiatives, public-private reimbursement programs, and increasing device adoption in hospitals and outpatient care.
• Asia Pacific: Fastest-growing region due to rising healthcare awareness, increasing insurance penetration, and government investments in healthcare infrastructure.
• Latin America: Moderate growth driven by evolving reimbursement policies, private healthcare expansion, and increased government support.
• Middle East & Africa: Emerging opportunities due to rising healthcare infrastructure investments, increasing insurance coverage, and growing adoption of advanced devices.

Key Players

The market is highly competitive, with leading medical device manufacturers, insurers, and healthcare providers actively shaping growth. Prominent players include:

• Medtronic
• Johnson & Johnson
• Abbott Laboratories
• Boston Scientific
• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Stryker Corporation
• Zimmer Biomet
• Becton, Dickinson and Company (BD)
• UnitedHealth Group
• CVS Health / Aetna
• Cigna Corporation
• Humana Inc.
• Allianz / Aviva / WellCare Health Plans

These organizations are focusing on strategic partnerships, mergers, and collaborations to expand reimbursement networks, increase market reach, and foster innovation in medical device technology.

Market Segmentation

By Claims:

• Underpaid
• Full Paid

By Application:

• Public Payers
• Private Payers

By Service Provider:

• Physician Office
• Hospitals
• Diagnostic Laboratories
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Medical Devices Reimbursement Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2026
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. COVID-19 Impact Analysis
• 2.5. Porter's Fiver Forces Analysis
• 2.6. Impact of Russia-Ukraine Conflict
• 2.7. PESTLE Analysis
• 2.8. Regulatory Analysis
• 2.9. Price Trend Analysis
  • 2.9.1. Current Prices and Future Projections, 2025-2033
  • 2.9.2. Price Impact Factors

3. Global Medical Devices Reimbursement Market Outlook, 2020-2033

• 3.1. Global Medical Devices Reimbursement Market Outlook, by Claims, Value (US$ Bn), 2020-2033
  • 3.1.1. Underpaid
  • 3.1.2. Full Paid
• 3.2. Global Medical Devices Reimbursement Market Outlook, by Application, Value (US$ Bn), 2020-2033
  • 3.2.1. Public payers
  • 3.2.2. Private payers
• 3.3. Global Medical Devices Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2020-2033
  • 3.3.1. Physician Office
  • 3.3.2. Hospitals
  • 3.3.3. Diagnostic Laboratories
  • 3.3.4. Others
• 3.4. Global Medical Devices Reimbursement Market Outlook, by Region, Value (US$ Bn), 2020-2033
  • 3.4.1. North America
  • 3.4.2. Europe
  • 3.4.3. Asia Pacific
  • 3.4.4. Latin America
  • 3.4.5. Middle East & Africa

4. North America Medical Devices Reimbursement Market Outlook, 2020-2033

• 4.1. North America Medical Devices Reimbursement Market Outlook, by Claims, Value (US$ Bn), 2020-2033
  • 4.1.1. Underpaid
  • 4.1.2. Full Paid
• 4.2. North America Medical Devices Reimbursement Market Outlook, by Application, Value (US$ Bn), 2020-2033
  • 4.2.1. Public payers
  • 4.2.2. Private payers
• 4.3. North America Medical Devices Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2020-2033
  • 4.3.1. Physician Office
  • 4.3.2. Hospitals
  • 4.3.3. Diagnostic Laboratories
  • 4.3.4. Others
• 4.4. North America Medical Devices Reimbursement Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 4.4.1. U.S. Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 4.4.2. U.S. Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 4.4.3. U.S. Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 4.4.4. Canada Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 4.4.5. Canada Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 4.4.6. Canada Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
• 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Medical Devices Reimbursement Market Outlook, 2020-2033

• 5.1. Europe Medical Devices Reimbursement Market Outlook, by Claims, Value (US$ Bn), 2020-2033
  • 5.1.1. Underpaid
  • 5.1.2. Full Paid
• 5.2. Europe Medical Devices Reimbursement Market Outlook, by Application, Value (US$ Bn), 2020-2033
  • 5.2.1. Public payers
  • 5.2.2. Private payers
• 5.3. Europe Medical Devices Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2020-2033
  • 5.3.1. Physician Office
  • 5.3.2. Hospitals
  • 5.3.3. Diagnostic Laboratories
  • 5.3.4. Others
• 5.4. Europe Medical Devices Reimbursement Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 5.4.1. Germany Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 5.4.2. Germany Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 5.4.3. Germany Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 5.4.4. Italy Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 5.4.5. Italy Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 5.4.6. Italy Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 5.4.7. France Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 5.4.8. France Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 5.4.9. France Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 5.4.10. U.K. Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 5.4.11. U.K. Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 5.4.12. U.K. Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 5.4.13. Spain Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 5.4.14. Spain Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 5.4.15. Spain Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 5.4.16. Russia Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 5.4.17. Russia Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 5.4.18. Russia Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 5.4.19. Rest of Europe Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 5.4.20. Rest of Europe Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 5.4.21. Rest of Europe Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
• 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Medical Devices Reimbursement Market Outlook, 2020-2033

• 6.1. Asia Pacific Medical Devices Reimbursement Market Outlook, by Claims, Value (US$ Bn), 2020-2033
  • 6.1.1. Underpaid
  • 6.1.2. Full Paid
• 6.2. Asia Pacific Medical Devices Reimbursement Market Outlook, by Application, Value (US$ Bn), 2020-2033
  • 6.2.1. Public payers
  • 6.2.2. Private payers
• 6.3. Asia Pacific Medical Devices Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2020-2033
  • 6.3.1. Physician Office
  • 6.3.2. Hospitals
  • 6.3.3. Diagnostic Laboratories
  • 6.3.4. Others
• 6.4. Asia Pacific Medical Devices Reimbursement Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 6.4.1. China Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 6.4.2. China Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 6.4.3. China Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 6.4.4. Japan Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 6.4.5. Japan Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 6.4.6. Japan Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 6.4.7. South Korea Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 6.4.8. South Korea Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 6.4.9. South Korea Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 6.4.10. India Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 6.4.11. India Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 6.4.12. India Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 6.4.13. Southeast Asia Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 6.4.14. Southeast Asia Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 6.4.15. Southeast Asia Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 6.4.16. Rest of SAO Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 6.4.17. Rest of SAO Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 6.4.18. Rest of SAO Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
• 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Medical Devices Reimbursement Market Outlook, 2020-2033

• 7.1. Latin America Medical Devices Reimbursement Market Outlook, by Claims, Value (US$ Bn), 2020-2033
  • 7.1.1. Underpaid
  • 7.1.2. Full Paid
• 7.2. Latin America Medical Devices Reimbursement Market Outlook, by Application, Value (US$ Bn), 2020-2033
  • 7.2.1. Public payers
  • 7.2.2. Private payers
• 7.3. Latin America Medical Devices Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2020-2033
  • 7.3.1. Physician Office
  • 7.3.2. Hospitals
  • 7.3.3. Diagnostic Laboratories
  • 7.3.4. Others
• 7.4. Latin America Medical Devices Reimbursement Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 7.4.1. Brazil Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 7.4.2. Brazil Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 7.4.3. Brazil Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 7.4.4. Mexico Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 7.4.5. Mexico Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 7.4.6. Mexico Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 7.4.7. Argentina Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 7.4.8. Argentina Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 7.4.9. Argentina Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 7.4.10. Rest of LATAM Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 7.4.11. Rest of LATAM Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 7.4.12. Rest of LATAM Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
• 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Medical Devices Reimbursement Market Outlook, 2020-2033

• 8.1. Middle East & Africa Medical Devices Reimbursement Market Outlook, by Claims, Value (US$ Bn), 2020-2033
  • 8.1.1. Underpaid
  • 8.1.2. Full Paid
• 8.2. Middle East & Africa Medical Devices Reimbursement Market Outlook, by Application, Value (US$ Bn), 2020-2033
  • 8.2.1. Public payers
  • 8.2.2. Private payers
• 8.3. Middle East & Africa Medical Devices Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2020-2033
  • 8.3.1. Physician Office
  • 8.3.2. Hospitals
  • 8.3.3. Diagnostic Laboratories
  • 8.3.4. Others
• 8.4. Middle East & Africa Medical Devices Reimbursement Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 8.4.1. GCC Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 8.4.2. GCC Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 8.4.3. GCC Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 8.4.4. South Africa Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 8.4.5. South Africa Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 8.4.6. South Africa Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 8.4.7. Egypt Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 8.4.8. Egypt Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 8.4.9. Egypt Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 8.4.10. Nigeria Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 8.4.11. Nigeria Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 8.4.12. Nigeria Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
  • 8.4.13. Rest of Middle East Medical Devices Reimbursement Market Outlook, by Claims, 2020-2033
  • 8.4.14. Rest of Middle East Medical Devices Reimbursement Market Outlook, by Application, 2020-2033
  • 8.4.15. Rest of Middle East Medical Devices Reimbursement Market Outlook, by Service Provider, 2020-2033
• 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. Company Vs Segment Heatmap
• 9.2. Company Market Share Analysis, 2025
• 9.3. Competitive Dashboard
• 9.4. Company Profiles
  • 9.4.1. Medtronic
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Product Portfolio
    • 9.4.1.3. Financial Overview
    • 9.4.1.4. Business Strategies and Developments
  • 9.4.2. Johnson & Johnson
  • 9.4.3. Abbott Laboratories
  • 9.4.4. Boston Scientific
  • 9.4.5. Siemens Healthineers
  • 9.4.6. GE Healthcare
  • 9.4.7. Philips Healthcare
  • 9.4.8. Stryker Corporation
  • 9.4.9. Zimmer Biomet
  • 9.4.10. Becton, Dickinson and Company (BD)

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations